Variant report
Variant | esv2761336 |
---|---|
Chromosome Location | chr7:70414425-70416962 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs577932452 | chr7:70416203-70416204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs545727807 | chr7:70416213-70416214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs1568866 | chr7:70416214-70416215 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs181896662 | chr7:70416223-70416224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10232361 | chr7:70416225-70416226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs186882034 | chr7:70416232-70416233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1568865 | chr7:70416237-70416238 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs61674992 | chr7:70416256-70416257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550623442 | chr7:70416258-70416259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562352947 | chr7:70416261-70416262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs78045878 | chr7:70416263-70416264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs151276998 | chr7:70416279-70416280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs566470028 | chr7:70416292-70416293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs533819039 | chr7:70416320-70416321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs548790524 | chr7:70416414-70416415 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567424288 | chr7:70416428-70416429 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs537967045 | chr7:70416497-70416498 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs556582660 | chr7:70416518-70416519 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs192078688 | chr7:70416519-70416520 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs184110098 | chr7:70416539-70416540 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs554201539 | chr7:70416564-70416565 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs141598897 | chr7:70416597-70416598 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs60221573 | chr7:70416646-70416647 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs529714736 | chr7:70416745-70416746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs150049124 | chr7:70416747-70416748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552614017 | chr7:70416790-70416791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs561345818 | chr7:70416810-70416811 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs576546500 | chr7:70416815-70416816 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs543974253 | chr7:70416831-70416832 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs62460371 | chr7:70416834-70416835 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs569654102 | chr7:70416852-70416853 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs147048104 | chr7:70416877-70416878 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs4719030 | chr7:70416886-70416887 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs368869443 | chr7:70416892-70416893 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs138285959 | chr7:70416908-70416909 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs527600633 | chr7:70416929-70416930 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs55678591 | chr7:70416940-70416941 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs567356160 | chr7:70416946-70416947 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs57691337 | chr7:70416950-70416951 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs4719031 | chr7:70416962-70416963 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Biliary cancer | 19435499 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Astrocytoma | 22246337 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16461572 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Bladder cancer | 21909424 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 21911935 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Chordoma | 18071362 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Dyslexia | 22102821 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:70416200-70416400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
2 | chr7:70416200-70416400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr7:70416200-70416600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr7:70416400-70417600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr7:70416600-70417400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr7:70416800-70417600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr7:70416800-70419600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |